A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
Clinical trial NCT05318937 · COMPLETED
Trial details
- NCT number
- NCT05318937
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2024-01-17
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.